Drug Information

Drug General Information
Drug ID
D0D2XA
Former ID
DNCL002487
Drug Name
REIC gene therapy
Indication Prostate cancer [ICD9: 185; ICD10:C61] Phase 1/2 [524416]
Company
Momotaro-Gene
Target and Pathway
Target(s) Dickkopf-3 Target Info Modulator [532606]
References
Ref 524416ClinicalTrials.gov (NCT01931046) Study of a Recombinant Adenovirus to Treat Localized Prostate Cancer. U.S. National Institutes of Health.
Ref 532606Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer. J Gastroenterol Hepatol. 2014 May;29(5):973-83.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.